< Back to previous page


A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
Patent Publication Number: EP3446126
Year filing: 2017
Year approval: 2020
Validated for IOF-key: Yes
Attributed to: Universitaire Associatie Brussel